Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Nov;113(5):631-640.
doi: 10.1111/ejh.14277. Epub 2024 Jul 19.

Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional study

Affiliations
Observational Study

Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional study

Jerzy Windyga et al. Eur J Haematol. 2024 Nov.

Abstract

Objectives: We aimed to characterise baseline disease and treatment burden in a large population with haemophilia A/B, both with (HAwI/HBwI) and without (HA/HB) inhibitors.

Methods: The prospective, non-interventional explorer6 study included patients ≥12 years old with severe HA, severe/moderate HB or HAwI/HBwI of any severity, treated according to local standard of care (excluding previous/current exposure to concizumab or emicizumab). Baseline characteristics and historical clinical data were collected and patient-reported outcomes, including treatment burden, were assessed.

Results: The explorer6 study enrolled 231 patients with haemophilia (84 HAwI/HBwI) from 33 countries. At baseline, patients with HA/HB treated with prophylaxis had the lowest median annualised bleeding rates (ABRs; 2.0), irrespective of haemophilia type; of these patients, 27.5% (HA) and 31.4% (HB) had target joints. Patients with HAwI/HBwI treated episodically reported the highest treatment burden. Of these patients, 28.5% (HAwI) and 25.1% (HBwI) performed sports activities in the month before screening.

Conclusion: Despite receiving routine clinical care, historical and baseline information from patients enrolled in explorer6 showed that patients with HA/HB treated episodically and patients with HAwI/HBwI had higher ABRs, higher treatment burden and participated in sports less than those with HA/HB treated with prophylaxis. Emerging treatments could be beneficial in addressing these unmet medical needs.

Keywords: haemophilia A; haemophilia B; health‐related quality of life; physical activity; symptom burden.

PubMed Disclaimer

References

REFERENCES

    1. Gualtierotti R, Solimeno LP, Peyvandi F. Hemophilic arthropathy: current knowledge and future perspectives. J Thromb Haemost. 2021;19(9):2112‐2121.
    1. Kloosterman F, Zwagemaker AF, Abdi A, Gouw S, Castaman G, Fijnvandraat K. Hemophilia management: huge impact of a tiny difference. Res Pract Thromb Haemost. 2020;4(3):377‐385.
    1. Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(suppl 6):1‐158.
    1. Thornburg CD, Duncan NA. Treatment adherence in hemophilia. Patient Prefer Adherence. 2017;11:1677‐1686.
    1. Putz P, Klinger M, Male C, Pabinger I. Lower physical activity and altered body composition in patients with haemophilia compared with healthy controls. Haemophilia. 2021;27(2):e260‐e266.

Publication types

MeSH terms

Grants and funding

LinkOut - more resources